Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Garcinia mangostana pericarp gel is a 4% herbal formulation developed by Meenakshi Ammal Dental College and Hospital for the treatment of chronic periodontitis. The gel is derived from the pericarp (rind) of the mangosteen fruit and is used as a local drug delivery adjunct to scaling and root planing (SRP). It exerts its therapeutic effects through antimicrobial, anti-inflammatory, and antioxidant activities, specifically targeting red complex microorganisms such as Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. By reducing the microbial load in subgingival tissues, the gel helps improve clinical parameters like pocket depth and attachment levels in patients with generalized chronic periodontitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Garcinia mangostana pericarp gel.